cotransporter-null mice exhibit absence of swelling and decrease in EAA release.
The role of NKCC1 in high-[K ϩ ] o -triggered swelling and glutamate release described above has been studied by pharmacological techniques. Although bumetanide is a potent inhibitor of the NKCCs, it also inhibits other ion transport proteins and GABA A channels (26, 34) . In this study, we used astrocytes isolated from the NKCC1-deficient mice established by Flagella et al. (6) . We report here that high-[K ϩ ] o -induced swelling was absent in NKCC1 Ϫ/Ϫ astrocytes. A significant decrease in intracellular Cl Ϫ and Na ϩ and release of glutamate was observed in NKCC1 Ϫ/Ϫ astrocytes. The results suggest that NKCC1 is important in regulation of astrocyte volume and intracellular Cl Ϫ and Na ϩ .
MATERIALS AND METHODS
Materials. Bumetanide, digitonin, Triton X-100, monensin, and gramicidin were purchased from Sigma (St. Louis, MO). Eagle's modified essential medium (EMEM) and Hanks' balanced salt solution (HBSS) were from Mediatech Cellgro (Herndon, VA). Fetal bovine serum was obtained from Hyclone Laboratories (Logan, UT). Collagen type I was from Collaborative Biomedical Products (Bedford, MA). Animals and genotype analysis. NKCC1 homozygous mutant and wild-type mice were obtained by breeding genetargeted NKCC1 heterozygous mutant mice, and genotypes were determined by a polymerase chain reaction (PCR) of DNA from tail biopsies as described previously (6) .
Primary culture of mouse cortical astrocytes. Dissociated cortical astrocyte cultures were established based on a method used in our previous study of rat cortical astrocyte cultures (32) . Cerebral cortices were removed from 1-day-old NKCC1 ϩ/ϩ or NKCC1 Ϫ/Ϫ mice. The cortices were incubated in a solution of 0.25 mg trypsin /ml HBSS for 25 min at 37°C. The tissue was then mechanically triturated and filtered through nylon meshes. The dissociated cells were rinsed and resuspended in EMEM containing 10% fetal bovine serum. Viable cells (1 ϫ 10 4 cells /well) were plated in 24-well plates coated with collagen type 1. Cultures were maintained in a 5% CO2 atmosphere at 37°C. The cultures were subsequently refed every 3 days throughout the study. To obtain morphologically differentiated astrocytes, confluent cultures (days 12-15 in culture) were treated with EMEM containing 0.25 mM dibutyryl cAMP (DBcAMP) for 7 days to induce differentiation. DBcAMP has been widely used to mimic neuronal influences on astrocyte differentiation (9, 35) . Experiments were routinely performed (see Figs. 4-10) on cultures treated with DBcAMP for 7 days.
Gel electrophoresis and Western blotting. Cortical astrocytes growing on culture dishes were washed with ice-cold phosphate-buffered saline (PBS; pH 7.4) that contained 2 mM EDTA and protease inhibitors. Cells were scraped from dishes and lysed by sonication at 4°C (32) . To obtain cellular lysates, cellular debris was removed by centrifugation and protein content of the cellular lysate was determined (29) . Samples and prestained molecular mass markers (Bio-Rad) were denatured in SDS reducing buffer (1:2 vol/vol; Bio-Rad) and heated at 37°C for 15 min before gel electrophoresis. The samples were then electrophoretically separated on 6% SDS gels, and the resolved proteins were electrophoretically transferred to a polyvinylidene difluoride membrane (32) . The blots were incubated in 7.5% nonfat dry milk in Trisbuffered saline and then incubated with a primary antibody. After rinsing, the blots were incubated with horseradish peroxidase-conjugated secondary IgG. Bound antibody was visualized with an enhanced chemiluminescence assay (ECL; Amersham). Anti-NKCC monoclonal antibody against the human colonic T84 epithelial NKCC (20) was used for detection of the cotransporter protein, and the same blot was probed with anti-␤ actin antibody as a control. A linear curve with 5-30 g of protein has been established for both anti-NKCC antibody and anti-␤ actin antibody (32) . In addition, the linear range of the ECL exposure course on the film was within 15-120 s (32) . Therefore, 30 g of protein was loaded in all immunoblots of the present study. In addition, the ECL exposure time was within 60 s.
Immunofluorescence staining. Cultured cells grown on collagen type I-coated coverslips were rinsed with PBS (pH 7.4) and fixed with 4% paraformaldehyde in PBS for 40 min at room temperature. After rinsing, cells were incubated with blocking solution (10% normal goat serum, 0.4% Triton X-100, and 1% bovine serum albumin in PBS) for 1 h. Cells were then incubated with anti-glial fibrillary acidic protein (GFAP) polyclonal (1:100) or anti-NKCC monoclonal antibodies (1:100) in blocking solution overnight at 4°C. Cells were rinsed with PBS and incubated with goat anti-mouse FITCconjugated or goat anti-rabbit Texas red-conjugated antibodies (1:200) for 2 h. Cell images were captured by laser scanning confocal microscope (Bio-Rad MRC 1000) as described previously (32) . Bio-Rad MRC-1024 Laser Sharp software (version 2.1T) was used to control the microscope and its settings. An identical setting was used to capture the negative control and experimental images.
Measurement of relative cell volume changes in single cell. Relative cell volume changes were estimated with videoenhanced differential interference contrast (DIC) microscopy, as described in our previous study (Ref. 33 , this issue). The same method has been reported by others (40 (33) . The mean cross-sectional area (CSA) of the cell body was calculated with MetaMorph image-processing software. The control CSA values were obtained when cells were exposed to HEPES-MEM only. Relative changes in CSA (CSAr) were calculated as experimental CSA divided by control CSA. After each experiment, relative cell volume changes in response to HEPES-MEM calibration buffers were measured. Salt concentrations in the buffers were held constant, and the osmolality (238, 277, and 312 mosmol/kgH2O) was adjusted by varying the buffer concentration of sucrose.
Assay for NKCC1 activity. NKCC1 activity was measured as bumetanide-sensitive K ϩ influx with 86 Rb as a tracer for K ϩ (32) . Cultured astrocytes were equilibrated for 10-30 min at 37°C with isotonic HEPES-MEM (312 mosmol/kgH2O). Cells were preincubated for 10 min in HEPES-MEM containing either 0 or 10 M bumetanide. For assay of cotransporter activity, cells were exposed to 1 Ci/ml of 86 Rb in HEPES-MEM for 3 min in the presence or absence of 10 M bumetanide. 86 Rb influx was stopped by rinsing cells with ice-cold 0.1 M MgCl2. Radioactivity of the cellular extract in 1% SDS was analyzed by liquid scintillation counting (1900CA; Packard, Downers Grove, IL). K ϩ influx rate was calculated and expressed as nanomoles of K ϩ per milligram of protein per minute. It has been established that the slope of 86 Rb uptake over 10 min is linear in astrocytes (32) . Bumetanide-sensitive K ϩ influx was obtained by subtracting the K ϩ influx rate in the presence of bumetanide from the total K ϩ influx rate. Quadruplicate determinations were obtained in each experiment throughout the study, and protein content was measured in each sample with a method described previously (29) . Statistical significance in the study was determined by ANOVA (Bonferroni-Dunn) at a confidence level of 95% (P Ͻ 0.05). (25) . Cultured astrocytes grown on collagen-coated coverslips were loaded with 10 M SBFI-AM at room temperature in HEPES-MEM containing 0.1% pluronic acid as described in our previous report (Ref. resulting ratios from each cell were fit with a three-parameter hyperbolic curve from which [Na ϩ ]i was calculated (4).
Intracellular Cl

D-[
14 C]Asp release measurement. Aspartate release was measured as described previously (Ref. 33 , this issue). Astrocytes grown on chamber slides were incubated overnight in 1 ml of complete EMEM containing 2 Ci/ml of D-[
14 C]Asp (specific activity of 55 mCi/mmol). The perfusing rate of the perfusion chamber was 1.5 ml/min. This chamber allows a complete change of the perfusing buffer within 2 min. The cells were perfused at a constant flow rate with HEPES-MEM containing 5.8 or 75 mM [K ϩ ]o in the presence or absence of 10 M bumetanide. The buffers and perfusion chamber were kept at 37°C. The perfusate was collected in 1-min intervals. At the end of the experiment, the cells were digested in 1% SDS. The radioactivity of samples was measured by liquid scintillation counting (Packard 1900CA). Calculation of fractional release was based on the following formula:
where Ct is the cpm value in the effluent at time t, Cend is the cpm value in the effluent at the end of the experiment, Sum(C t:Cend) is the total cpm value in the effluent from time t to the end of the experiment (28), and Cremain is the cpm value left in the cells at the end of the experiment.
RESULTS
Absence of NKCC1 protein expression in cultured cortical astrocytes isolated from NKCC1
Ϫ/Ϫ mice. Mating of heterozygous mice yielded live offspring of all three genotypes in a Mendelian ratio of 1:2: Fig. 1A , a single DNA band (ϳ105 bp) was detected in a tail biopsy of the NKCC1 ϩ/ϩ mouse. In contrast, a larger DNA band (ϳ156 bp) was found in the NKCC1 Ϫ/Ϫ tail biopsy. In a heterozygous sample, both PCR products were present.
To analyze expression of the NKCC1 protein in cultured NKCC1
Ϫ/Ϫ cortical astrocytes, cellular lysates were obtained from both cultured NKCC1 ϩ/ϩ and NKCC1 Ϫ/Ϫ astrocytes. Immunoblotting revealed that an ϳ152 Ϯ 5.7 kDa protein was recognized by an anti-NKCC antibody in undifferentiated (ϪDBcAMP) and differentiated (ϩDBcAMP) NKCC1 ϩ/ϩ astrocytes
Fig. 1. Genotyping and immunoblot analysis for Na
. A: DNA samples isolated from tail biopsies were used as polymerase chain reaction (PCR) templates. Three primers were included in the reaction mixture: forward and reverse primers corresponding to an exon sequence of the wild-type gene and a reverse primer complementary to sequence of the mutant gene (6) . B: cell differentiation was induced by dibutyryl cAMP (DBcAMP). Cell lysates from cultured astrocytes (NKCC1 ϩ/ϩ and NKCC1 Ϫ/Ϫ ) were separated by 6% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with either an anti-NKCC monoclonal antibody or an anti-␤ actin antibody. The blots were visualized by enhanced chemiluminescence. This is a representative experiment of n ϭ 3. (Fig. 1B) . In contrast, no protein band was detected by the anti-NKCC antibody in either undifferentiated or differentiated NKCC1
Ϫ/Ϫ astrocytes. The lack of NKCC1 bands was not due to an insufficient amount of protein having been loaded, because, as shown on the same blot, a similar amount of ␤-actin protein (ϳ58 Ϯ 5.2 kDa) was observed in samples from both NKCC1 trocytes were positively stained for the glial marker GFAP. Anti-NKCC antibody immunoreactive fluorescence signals were observed in both undifferentiated and differentiated NKCC1 ϩ/ϩ astrocytes (Fig. 2, B and E). Colocalization of GFAP and the cotransporter is shown in Fig. 2 , C and F. This is consistent with our previous findings in cultured rat cortical astrocytes (32) . In NKCC1 Ϫ/Ϫ astrocytes, DBcAMP induced differentiation in a similar fashion as in NKCC1 ϩ/ϩ astrocytes (Fig. 2, a and d) . Expression of GFAP was shown in both undifferentiated and differentiated NKCC1 Ϫ/Ϫ astrocytes (Fig. 2, a and d) . However, no immunoreactive signals were detected in NKCC1
Ϫ/Ϫ astrocytes with the anti-NKCC antibody (Fig. 2, b and e) . Only GFAP signals appeared in a double-staining image (Fig. 2, c and f) 36 Cl increase in NKCC1 ϩ/ϩ astrocytes (P Ͻ 0.05; Fig. 4A ). As shown in Fig. 4B Ϫ/Ϫ astrocytes (P Ͻ 0.001; Fig. 5, A and B) .
ϩ/ϩ and NKCC1 Ϫ/Ϫ astrocytes (Fig. 5, A and B) , which has been suggested to be attributable in part to activation of Na (Fig. 6B) . Pharmacological inhibition and genetic ablation of NKCC1 have similar effects on astrocyte swelling. This indicates that NKCC1 is essential in astrocyte volume regulation. Therefore, we further investigated how NKCC1 Ϫ/Ϫ astrocytes respond to osmotic stress. First, we evaluated regulatory volume increase (RVI) in both NKCC1 ϩ/ϩ and NKCC1 Ϫ/Ϫ astrocytes. As shown in Fig. 7A, when NKCC1 ϩ/ϩ astrocytes were exposed to hypertonic HEPES-MEM (367 mosmol/kgH 2 O), CSA r decreased quickly and was 0.92 Ϯ 0.01 at maximum cell shrinkage. CSA r in NKCC1 ϩ/ϩ recovered by 63.0 Ϯ 4.4% at 20 min of hypertonic exposure (Fig. 7, A and B,  inset) . As NKCC1 ϩ/ϩ astrocytes were returned to an isotonic HEPES-MEM (310 mosmol/kgH 2 O), CSA r was further increased, followed by a secondary regulatory volume decrease (RVD; Fig. 7A ). As shown in Fig. 7B , CSA r in NKCC1 Ϫ/Ϫ astrocytes decreased in response to the hypertonic challenge. At maximum cell shrinkage, CSA r was 0.93 Ϯ 0.01 (Fig. 7B) . Moreover, RVI was impaired in NKCC1 Ϫ/Ϫ astrocytes (Fig. 7B) . Overall, there was only 4.3 Ϯ 1.7% RVI in NKCC1 Ϫ/Ϫ astrocytes at 20 min of hypertonic exposure (Fig. 7B, inset) . In addition, after returning to isotonic conditions, NKCC1 Ϫ/Ϫ astrocytes remained shrunken at a CSA r of 0.96 Ϯ 0.01, which was significantly lower than basal levels (P Ͻ 0.01). These results indicate that the NKCC1 is essential for RVI in mouse cortical astrocytes.
We next examined RVD in NKCC1
ϩ/ϩ and NKCC1 Ϫ/Ϫ astrocytes in response to a hypotonic challenge. When NKCC1 ϩ/ϩ astrocytes were exposed to hypotonic HEPES-MEM (247 mosmol/kgH 2 O), CSA r increased and reached a maximum level of 1.11 Ϯ 0.02 (Fig. 8A) . Cell volume subsequently decreased, and a RVD of 48.5 Ϯ 5.0% developed after 20 min of hypotonic exposure (Fig. 8, A and B, inset) . In NKCC1 Ϫ/Ϫ astrocytes, cell swelling was not significantly different from that of NKCC1 ϩ/ϩ astrocytes (CSA r ϭ 1.08 Ϯ 0.01 in NKCC1
Ϫ/Ϫ vs. 1.11 Ϯ 0.02 in NKCC1 ϩ/ϩ ; P Ͼ 0.05). Interestingly, the rate of RVD in NKCC1 Ϫ/Ϫ astrocytes was faster (CSA r ϭ 0.002%/min in NKCC1 ϩ/ϩ vs. 0.009%/min in NKCC1 Ϫ/Ϫ astrocytes; P Ͻ 0.05). After 20 min of hypotonic exposure, an RVD of 86.6 Ϯ 8.3% was obtained, which was significantly higher than the 48.5% in NKCC1 ϩ/ϩ astrocytes (Fig. 8B, inset) . This suggests that other ion extrusion systems may be upregulated in NKCC1 part to swelling, we anticipated that preventing cell swelling by inhibition of NKCC1 activity would reduce glutamate release. As shown in (Fig. 9B) . Compared with the value in NKCC1 ϩ/ϩ astrocytes, the peak release was ϳ30% less in NKCC1
Ϫ/Ϫ astrocytes (P Ͻ 0.05; Fig. 9B and inset) . This is in agreement with the bumetanide-mediated effect in NKCC1 ]Asp was the same as that described above. In the presence of DIDS, there was no change in phase I release; however, the peak release of phase II was blocked by DIDS. In the DIDS-treated group, the peak release of D-[ 14 C]Asp during phase II was not significantly different from basal levels (0.25 Ϯ 0.04 vs. 0.16 Ϯ 0.02% fractional release per minute, n ϭ 6-12; Fig. 10A and inset) . In NKCC1 Ϫ/Ϫ astrocytes, DIDS did not significantly affect the phase I release of D-[
14 C]Asp (0.13 Ϯ 0.01 vs. 0.17 Ϯ 0.02% fractional release per minute; P Ͻ 0.05). However, the remaining release during phase II was abolished in the presence of DIDS (Fig. 10B and inset) rise in rat astrocytes (28, 32 of K ϩ influx and accumulation of intracellular 36 Cl were not significantly different in NKCC1 Ϫ/Ϫ and NKCC1 ϩ/ϩ cortical astrocytes. This implies that a role for NKCC1 in maintenance of resting intracellular levels of K ϩ and Cl Ϫ in astrocytes is negligible. It is possible that the intracellular K ϩ concentration is maintained by mechanisms such as Na (24, 26) . Inhibition of NKCC1 by bumetanide leads to cell shrinkage under isotonic conditions in cells such as retinal pigment epithelia, ventricular myocytes, and vascular endothelial cells (26) . However, bumetanide has no effect on the basal volume of C6 glioma and vascular smooth muscle cells (26) . In our study, neither inhibition of NKCC1 activity by bumetanide nor genetic ablation of NKCC1 affected the baseline volume in astrocytes. One possible explanation for the lack of an effect is that NKCC1 is not essential for maintenance of cell volume in mouse cortical astrocytes. Other mechanisms, such as the coupled activities of Na ϩ /H ϩ and Cl Ϫ /HCO 3 Ϫ exchangers, which are expressed in astrocytes (3), may be able to maintain cell volume under control conditions. NKCC1 is one of the principal volume regulatory transporters in RVI (24, 26) . However, contradictory results about RVI have been observed in rat astrocytes (24) . No RVI was observed when cultured rat cortical astrocytes were exposed to a hypertonic medium made with mannitol or NaCl (17, 23) . However, rat astrocytes shrank and exhibited RVI in hypertonic buffer made with sucrose (5) . The basis of the lack of RVI in rat astrocytes in these studies is unclear, although it could be attributable to intracellular ion concentrations such as Cl Ϫ [see review by O'Neill (24)]. To our knowledge, RVI in mouse cortical astrocytes has not been extensively examined before. In the present study, NKCC1 ϩ/ϩ mouse cortical astrocytes underwent RVI within 10 min after a hypertonic shrinkage. Cell volume was completely recovered as NKCC1 ϩ/ϩ cortical astrocytes were returned to isotonic conditions. In contrast, RVI was absent in NKCC1 Ϫ/Ϫ cortical astrocytes. In addition, on returning cells to the isotonic solutions, cell volume of NKCC1 Ϫ/Ϫ cortical astrocytes failed to recover to basal levels. This is the first study to firmly establish that hypertonic RVI occurs in mouse cortical astrocytes and that the absence of NKCC1 completely impairs the RVI function in mouse cortical astrocytes.
In addition to RVI, NKCC1 is also involved in a secondary RVI when cells are returned to isotonic conditions after hypotonic cell swelling (post-RVD RVI; Ref.
8). NKCC1
ϩ/ϩ cortical astrocytes exhibited RVD and post-RVD RVI. Interestingly, in NKCC1 Ϫ/Ϫ cortical astrocytes, post-RVD RVI occurred but at signifi- cantly slower rates (Fig. 8B) . This implies that other cell volume regulatory ion transport mechanisms can compensate for the loss of NKCC1 during this process. However, it is unclear why these ion transport mechanisms are functional after isosmotic shrinkage but not in hypertonic shrinkage. It could be that a loss of osmotically active molecules, such as KCl, under isosmotic shrinkage removes a factor(s) that otherwise inhibits these ion transport mechanisms (24) . Moreover, the RVD rate in NKCC1 Ϫ/Ϫ cortical astrocytes is significantly faster than that in NKCC1 ϩ/ϩ cortical astrocytes. We speculate that some ion efflux pathways, such as K ϩ and Cl Ϫ channels or K-Cl cotransporters, could be upregulated in NKCC1 Ϫ/Ϫ cortical astrocytes. Further investigation is needed to verify this speculation.
Role (1, 18) . It is generally believed that astrocytes reduce cell volume by the efflux of chloride, glutamate, and other anions through VSOACs (1, 18, 27) . However, the channels responsible for VSOAC currents in astrocytes remain to be identified (31) . In addition to the swelling stimulus, Cl Ϫ channels are regulated by a variety of signal transduction pathways, such as those involving Ca 2ϩ / calmodulin, cAMP, and protein kinase C (1, 14) .
In the current study, high However, Ca 2ϩ -free medium plus 50-100 M EGTA only moderately inhibits the [K ϩ ] o -induced taurine release (22) and has no effect on glutamate release in rat astrocytes (28) . This is different from our observations on the release of D-[
14 C]Asp in mouse astrocytes. The cause of this discrepancy is unclear. It could be due to species differences (rat vs. mouse) or different cell culture conditions (differentiated vs. undifferentiated astrocytes).
In summary, with the use of both pharmacological and transgenic knockout approaches, we report here that NKCC1 contributes to baseline [ 
